Home » Topics » Regulatory

Regulatory
RSS

Lanicemine now claimed for treatment of headache

Nov. 2, 2000

No Comments

Microsponge formulation of 5-FU approved by FDA for actinic keratoses

Oct. 31, 2000

No Comments

Alza's Caelyx approved in E.U. for advanced ovarian cancer

Oct. 27, 2000

No Comments

Unimed submits NDA for eprosartan/hydrochlorothiazide combination tablet

Oct. 27, 2000

No Comments

Remicade recommended for approval in Europe for broader application

Oct. 26, 2000

No Comments

First oral chemotherapy for colorectal cancer recommended for approval in Europe

Oct. 24, 2000

No Comments

Once-weekly Fosamax approved by FDA

Oct. 24, 2000

No Comments

Prilosec receives positive recommendation for OTC status

Oct. 24, 2000

No Comments

SkyePharma's Solaraze earns FDA approval

Oct. 23, 2000

No Comments

Meningococcal C meningitis vaccine approved for very young infants

Oct. 19, 2000

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

Lanicemine now claimed for treatment of headache

Microsponge formulation of 5-FU approved by FDA for actinic keratoses

Alza's Caelyx approved in E.U. for advanced ovarian cancer

Unimed submits NDA for eprosartan/hydrochlorothiazide combination tablet

Remicade recommended for approval in Europe for broader application

First oral chemotherapy for colorectal cancer recommended for approval in Europe

Once-weekly Fosamax approved by FDA

Prilosec receives positive recommendation for OTC status

SkyePharma's Solaraze earns FDA approval

Meningococcal C meningitis vaccine approved for very young infants

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Regulatory RSS

Regulatory
RSS